Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
about
Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesisClaudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapyProgress toward in vivo use of siRNAs-IIThe Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic CancersLipid-based vectors for siRNA deliveryFolate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.Claudin-containing exosomes in the peripheral circulation of women with ovarian cancerClaudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activationAndrogen-dependent sertoli cell tight junction remodeling is mediated by multiple tight junction components.Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modificationsPrognostic biomarkers in ovarian cancer.Small RNA combination therapy for lung cancerPyruvate kinase M2-specific siRNA induces apoptosis and tumor regressionSilencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells.Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsNanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in miceThe effects of claudin 14 during early Wallerian degeneration after sciatic nerve injury.CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.Synergistic silencing: combinations of lipid-like materials for efficacious siRNA deliveryDown Regulation of CLDND1 Induces Apoptosis in Breast Cancer Cells.Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids.ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 miceGalactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.Lipid-like Nanoparticles for Small Interfering RNA Delivery to Endothelial CellsNeutral polymeric micelles for RNA deliveryTargeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Indium-Labeling of siRNA for Small Animal SPECT Imaging.Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.Emerging roles of claudins in human cancerLiposome-like Nanostructures for Drug Delivery.Lipidic systems for in vivo siRNA delivery.Claudin and ovarian cancer.Oligonucleotide delivery in cancer therapy.The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.Engineering Nanocarriers for siRNA Delivery.Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.Lipid-based nanoparticles in the systemic delivery of siRNA.Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
P2860
Q26787279-29AC782E-9CD7-48DC-BFDB-BE816B91F341Q26851347-C59109A6-8B5A-4B27-8FBA-3B457E90B76FQ28255877-AF91E3AC-07EE-4014-AEEE-71D61F34AAE7Q28551531-DA434913-4992-4276-AF3F-B3DC745FCBB7Q28828356-C9210C66-F8FC-42DC-A39E-994C9191EADBQ30365844-0A3670CA-B839-442A-8A6E-B9A5E51D7ED2Q33484414-CAFAE111-21CE-4FDC-8D3E-E78AF75B7308Q33618564-6C397FB7-95BC-4565-9E25-B88BE2F2B227Q33821598-92069B47-E4B7-4EFB-B462-30DE2C0CEDBEQ33884564-6C483A8B-4FC9-4342-B57E-3D15D77F15C3Q34086636-0B59184D-20D9-497F-89A4-07753985C01AQ34120092-F68E44B8-00D5-45D0-88E6-9C808405EEE0Q34136997-42117062-AB2D-4B34-BA67-C459D137D940Q34395225-B7C1BC61-79D7-4D8A-9CB9-AFCB943B8EA7Q34490603-780625EE-5187-49B5-8BC8-4C3EEDF1AD44Q34491276-4D298031-78E7-4D01-8076-EE2E008844EBQ34994831-B81F5564-6A56-4FF5-B6B8-820A3D2F8E07Q35046936-7E97EC76-93D4-4942-9C37-43DD5FE56175Q35067887-542FAAEB-A47E-429A-99B9-7E53E7C7A052Q35238275-EA701868-55CD-40EC-9D94-1D1705EA89ABQ35666010-F1348C4D-BF6B-49B2-8A35-002EFF0E487CQ35853451-1E6E546C-8A22-4E45-8CF1-0DFE472A1B64Q36122624-C8084D3F-2C97-4CAB-9A5A-2B9576F566CAQ36172753-5A4FBB01-34C0-490B-B516-2E33A33EE9A9Q36544617-FFD2740E-CB29-41A5-A2CC-048FA99F17CFQ36588308-1E340526-B5AD-457F-8F0B-310AA20CBFB0Q36763827-F7578D4A-286F-470E-8290-F5BFC27AF876Q36786792-D51F433D-104B-4403-8D86-40F8EB9BFE38Q37076674-187EDE86-CE04-4F29-B492-860E01A77A75Q37119791-6E058988-B94E-4506-A94F-79806A6D0F16Q37225107-64EF3DCB-5B96-46EF-B537-7250114D6FB3Q37424654-2B66DE5D-28B5-4E46-9AE5-0D6625DEE3DEQ37598096-2153A0F2-B3AD-4015-950D-94016F2FD8CDQ37611453-86A066B0-DB96-443B-9932-24DE4B604C2AQ37803214-FF452B2D-633A-4218-8627-C3EC6F1FAEEBQ37813173-5DA6A227-C765-4A07-93B9-1114328D3BADQ37849727-6D83E98A-4838-4CA9-83CB-59AE2D688D15Q37866083-F964C6A9-D82D-4B1C-8853-454E9D46F4C2Q38172634-AB952714-2452-428E-804F-C766CC98B3BDQ38378261-9C348F90-1AE9-4278-8AE8-783B8B2341B6
P2860
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@ast
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@en
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@nl
type
label
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@ast
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@en
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@nl
prefLabel
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@ast
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@en
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@nl
P2093
P2860
P356
P1476
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
@en
P2093
Daniel G Anderson
David A Bumcrot
Geoffrey Cole
Janet A Sawicki
Kevin Love
Michael Goldberg
Weidan Peng
Yu-Hung Huang
Yunhua Bao
P2860
P304
P356
10.1073/PNAS.0813348106
P407
P577
2009-02-10T00:00:00Z